Accession Number: | 0001593968-21-002107 |
Date: | 2021-09-08 |
Issuer: | KARUNA THERAPEUTICS, INC. (KRTX) |
Original Submission Date: |
IGNELZI TROY A.
C/O KARUNA THERAPEUTICS, INC.
99 HIGH STREET, 26TH FLOOR
BOSTON, MA 02110
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-09-08 | M | 7,000 | a | $9.20 | 25,000 | direct | ||
COMMON STOCK | 2021-09-08 | S | 7,000 | d | $116.16 | 18,000 | direct | ||
COMMON STOCK | 2021-09-08 | M | 600 | a | $9.20 | 18,600 | direct | ||
COMMON STOCK | 2021-09-08 | S | 600 | d | $121.01 | 18,000 | direct | ||
COMMON STOCK | 2021-09-09 | M | 500 | a | $9.20 | 18,500 | direct | ||
COMMON STOCK | 2021-09-09 | S | 500 | d | $120.05 | 18,000 | direct | ||
COMMON STOCK | 2021-09-10 | M | 1,900 | a | $9.20 | 19,900 | direct | ||
COMMON STOCK | 2021-09-10 | S | 1,900 | d | $120.05 | 18,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 9.2 | 2021-09-08 | deemed execution date | M | 7,000 (d) | 2029-03-21 | common stock 7,000 | $9.20 | 182,725 | direct | ||
OPTION (RIGHT TO BUY) | 9.2 | 2021-09-08 | deemed execution date | M | 600 (d) | 2029-03-21 | common stock 600 | $9.20 | 182,125 | direct | ||
OPTION (RIGHT TO BUY) | 9.2 | 2021-09-09 | deemed execution date | M | 500 (d) | 2029-03-21 | common stock 500 | $9.20 | 181,625 | direct | ||
OPTION (RIGHT TO BUY) | 9.2 | 2021-09-10 | deemed execution date | M | 1,900 (d) | 2029-03-21 | common stock 1,900 | $9.20 | 179,725 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 15, 2021. |
f2 | the price reported in column 4 is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $116.11 to $116.24, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
f3 | this option vested as to 25% of the shares on the first anniversary of the vesting commencement date of march 1, 2019, with additional vesting as to 12.5% of the shares underlying the option award on each six month period thereafter. |